BA
TMO icon

Bard Associates’s Thermo Fisher Scientific TMO Stock Holding History

Bard Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Buy
26
+13
+100% +$6.24K ﹤0.01% 216
2026
Q1 		$6.4K Hold
13
– – ﹤0.01% 222
2025
Q4 		$7.54K Buy
+13
New +$7.35K ﹤0.01% 214

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bard Associates's TMO Position: Q2 2026 in Review

Bard Associates increased its Thermo Fisher Scientific (TMO) stake by 100% in Q2 2026, buying an estimated $6.24K and bringing the position to 26 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #216.

Bard Associates first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bard Associates held 26 shares of Thermo Fisher Scientific worth $13K as of Q2 2026.
  • Bard Associates bought 13 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.24K.
  • Thermo Fisher Scientific made up ﹤0.01% of Bard Associates's portfolio in Q2 2026, its #216 holding.
  • Bard Associates first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.